scorecardresearch
Add as a preferred source on Google
Sunday, November 9, 2025
TopicAnti-cancer drugs

Topic: anti-cancer drugs

Drug costs form chunk of out-of-pocket spending on health in India. This could change with GST reforms

The Union Finance Ministry announced a five percent GST on all drugs and medicines from 22 September—down from the earlier 12 percent GST.

PGIMER report bats for new-age targeted lung cancer therapies to be included in AB-PMJAY

Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly diagnosed advanced or metastatic non-small cell lung cancer.

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

On Camera

I am a dog lover, but we don’t know how to win the war on strays

We have failed terribly at two important things. One, we are reacting to this issue only emotionally, not logically. And two, we are not asking the right questions.

In NCLAT’s WhatsApp ruling, reminder of India’s cautious view of competition disputes involving Big Tech

WhatsApp privacy policy case is among a string of matters involving practices like restrictive platform rules, pricing & billing policies, reflecting India’s tight scrutiny of market dominance.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.